<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Military Medical Academy Reports</journal-id><journal-title-group><journal-title xml:lang="en">Russian Military Medical Academy Reports</journal-title><trans-title-group xml:lang="ru"><trans-title>Известия Российской Военно-медицинской академии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2713-2315</issn><issn publication-format="electronic">2713-2323</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">643161</article-id><article-id pub-id-type="doi">10.17816/rmmar643161</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pulmonary Hypertension in Pregnancy</article-title><trans-title-group xml:lang="ru"><trans-title>Легочная гипертензия при беременности</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6599-9906</contrib-id><contrib-id contrib-id-type="spin">8450-3464</contrib-id><name-alternatives><name xml:lang="en"><surname>Rudaeva</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Рудаева</surname><given-names>Елена Владимировна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine), Associate Professor</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент</p></bio><email>rudaevaeg1951@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3269-9018</contrib-id><contrib-id contrib-id-type="spin">5854-6890</contrib-id><name-alternatives><name xml:lang="en"><surname>Mozes</surname><given-names>Vadim G.</given-names></name><name xml:lang="ru"><surname>Мозес</surname><given-names>Вадим Гельевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>докт. мед. наук, профессор</p></bio><email>vadimmoses@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3729-616X</contrib-id><contrib-id contrib-id-type="spin">8816-7409</contrib-id><name-alternatives><name xml:lang="en"><surname>Kashtalap</surname><given-names>Vasily V.</given-names></name><name xml:lang="ru"><surname>Кашталап</surname><given-names>Василий Васильевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>докт. мед. наук, профессор</p></bio><email>v_kash@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6966-2681</contrib-id><contrib-id contrib-id-type="spin">7696-6446</contrib-id><name-alternatives><name xml:lang="en"><surname>Elgina</surname><given-names>Svetlana I.</given-names></name><name xml:lang="ru"><surname>Елгина</surname><given-names>Светлана Ивановна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>докт. мед. наук, профессор</p></bio><email>Elginas.i@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kemerovo State Medical University</institution></aff><aff><institution xml:lang="ru">Кемеровский государственный медицинский университет</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kemerovo State University</institution></aff><aff><institution xml:lang="ru">Кемеровский государственный университет</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Research Institute for Complex Issues of Cardiovascular Diseases</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-05-25" publication-format="electronic"><day>25</day><month>05</month><year>2025</year></pub-date><volume>44</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>103</fpage><lpage>112</lpage><history><date date-type="received" iso-8601-date="2024-12-18"><day>18</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-01-19"><day>19</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2025,</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-05-25"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/RMMArep/article/view/643161">https://journals.eco-vector.com/RMMArep/article/view/643161</self-uri><abstract xml:lang="en"><p>Pregnancy complicated with pulmonary hypertension is a severe and dangerous condition. Due to changes in the maternal cardiovascular system, the symptoms of pulmonary hypertension during pregnancy may be more severe compared with those in non-pregnant women. This review describes effective treatment methods, including preconception counseling and monitoring, overall care, labor and postpartum care, contraception, maternal and fetal outcomes, and principles of diagnostics and management. The review was performed in line with the PRISMA guidelines across eLibrary and PubMed databases in 2024. The search queries were легочная артериальная гипертензия у беременных (pulmonary hypertension in pregnancy), осложнения беременности и родов при легочной артериальной гипертензии (complications of pregnancy and labor in pulmonary hypertension), прегравидарная подготовка у пациенток с легочной артериальной гипертензией (preconception care in patients with pulmonary hypertension), контрацепция у пациенток с легочной артериальной гипертензией (contraception in patients with pulmonary hypertension), анестезия при родоразрешении беременных с легочной артериальной гипертензией (anesthesia in labor in pregnant women with pulmonary arterial hypertension). The review included the studies of any design published in these databases over the past decade. The initial search identified 235 articles, yielding 89 titles after removal of duplicates, abstracts, and summaries without an available full-text version. After removal of 56 articles that did not meet the inclusion criteria, 33 full-text articles were analyzed and included in the review. It was found that pulmonary hypertension in pregnancy is a rare condition associated with a high complication rate and mortality. The study data obtained in recent years demonstrate better survival rates in the patients with such condition. The management and delivery of pregnant women with comorbid pulmonary hypertension are difficult. For successful outcomes, they require a personalized and multidisciplinary approach. All women with pulmonary hypertension should avoid pregnancy due to the high risk of maternal mortality. Close maternal and fetal observation by a multidisciplinary team during pregnancy and labor is recommended in case of pregnancy maintenance. There is no current consensus on drug and dose selection for women with pulmonary hypertension. The choice of the abortion time, labor time, and anesthesia is based on individual needs and risk assessment. The possible association between pulmonary hypertension and pre-eclampsia deserves special attention and further study.</p></abstract><trans-abstract xml:lang="ru"><p>Беременность, осложненная легочной артериальной гипертензией, является тяжелым и опасным состоянием. Изменения в сердечно-сосудистой системе матери предполагают, что легочная артериальная гипертензия во время беременности может проявляться более тяжелыми симптомами по сравнению с таковыми у небеременных. В данном обзоре освещены эффективные методы лечения, включая консультирование и мониторинг на прегравидарном этапе наблюдения, общий уход, роды и послеродовый период, вопросы контрацепции, исходы для матери и плода, принципы диагностики и ведения. Проведен обзор литературы в соответствии с рекомендациями PRISMA. Обзор публикаций проведен в 2024 г. в базах eLibrary и PubMed. Использовались следующие поисковые запросы: «легочная артериальная гипертензия у беременных», «осложнения беременности и родов при легочной артериальной гипертензии», «прегравидарная подготовка у пациенток с легочной артериальной гипертензией», «контрацепция у пациенток с легочной артериальной гипертензией», «анестезия при родоразрешении беременных с легочной артериальной гипертензией». В обзор включены исследования любого дизайна, опубликованные в указанных базах за последние 10 лет. Первично было отобрано 235 работ, из которых после удаления дубликатов, тезисных публикаций и резюме статей без доступной полнотекстовой версии осталось 89. После удаления 56 статей, которые не соответствовали критериям включения, было проанализировано 33 полнотекстовых статей. Установлено, что легочная артериальная гипертензия во время беременности встречается редко и связана с высокой частотой осложнений и летальности. Получены данные об улучшении выживаемости таких пациенток в последние годы. Беременные с сопутствующей патологией в варианте легочной артериальной гипертензии сложны в ведении и родоразрешении, требуют индивидуального и мультидисциплинарного подхода для достижения успешных результатов. Все пациентки с легочной артериальной гипертензией должны избегать беременности ввиду высокого риска материнской смертности. При пролонгировании беременности показано тщательное наблюдение за матерью и плодом во время беременности и в родах многопрофильной командой специалистов. В настоящее время нет единого мнения по выбору лекарств и дозировки для женщин с легочной артериальной гипертензией. Сроки прерывания беременности, родов и выбор анестезии обусловлен индивидуальными потребностями и оценкой риска. Потенциальная связь между легочной артериальной гипертензией и преэклампсией заслуживает особого внимания и дальнейшего изучения.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>pulmonary hypertension</kwd><kwd>maternal mortality</kwd><kwd>risk assessment</kwd><kwd>pre-eclampsia</kwd><kwd>pregnancy maintenance</kwd><kwd>abortion</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>легочная артериальная гипертензия</kwd><kwd>материнская смертность</kwd><kwd>оценка риска</kwd><kwd>преэклампсия</kwd><kwd>пролонгирование беременности</kwd><kwd>прерывание беременности</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hemnes AR, Kiely DG, Cockrill BA, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015;5(3):435–465. doi: 10.1086/682230</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18(9):1119–1128. doi: 10.1002/ejhf.594</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hassoun PM. Pulmonary Arterial Hypertension. N Engl J Med. 2021;385(25):2361–2376. doi: 10.1056/NEJMra2000348</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Sysol JR, Machado RF, Machado R. Classification and pathophysiology of pulmonary hypertension. Continuing Cardiology Education. 2018;4(1):2–12.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Avdeev SN, Barbarash OL, Valieva ZS, et al. 2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2024; 29(11):170–250. EDN: MYEOVA doi: 10.15829/1560-4071–2024-6161</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi: 10.1183/13993003.01913-2018</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019;53(1):1802148. doi: 10.1183/13993003.02148–2018</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31(7):1650–1657. doi: 10.1016/s0735-1097(98)00162-4</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Luo J, Shi H, Xu L, et al. Pregnancy outcomes in patients with pulmonary arterial hypertension: A retrospective study. Medicine (Baltimore). 2020;99(23): e20285. doi: 10.1097/MD.0000000000020285</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hjalmarsson C, Rådegran G, Kylhammar D, et al. Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension. Eur Respir J. 2018;51(5):1702310. doi: 10.1183/13993003.02310-2017</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Klinicheskiye rekomendatsii — Normal’naya beremennost’ — 2023–2024–2025 (15.02.2024) — Utverzhdeny Minzdravom RF. Available from: http://disuria.ru/_ld/13/1396_kr23Z32Z36MZ.pdf (In Russ.).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kiely DG, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG. 2010;117(5):565–574. doi: 10.1111/j.1471-0528.2009.02492.x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Boyers S, Nayyar R, Melov SJ, et al. A case series describing the multidisciplinary management of pulmonary arterial hypertension in pregnancy: Time for optimism. Aust N Z J Obstet Gynaecol. 2023;63(1):66–73. doi: 10.1111/ajo.13557</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Daraz Y, Murthy S, Wolfe D. Pregnancy in Pulmonary Arterial Hypertension: A Multidisciplinary Approach. J Cardiovasc Dev Dis. 2022;9(6):196. doi: 10.3390/jcdd9060196</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Krishnan S, Fricke EM, Cordoba M, et al. Pulmonary hypertension complicating pregnancy. Current Pulmonology Reports. 2021; 10:71–83. doi: 10.1007/s13665-021-00275-1</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi: 10.1093/eurheartj/ehy340</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–975. doi: 10.1183/13993003.01032–2015</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Corbach N, Berlier C, Lichtblau M, et al. Favorable Pregnancy Outcomes in Women With Well-Controlled Pulmonary Arterial Hypertension. Front Med (Lausanne). 2021;8:689764. doi: 10.3389/fmed.2021.689764</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Olsson KM, Delcroix M, Ghofrani HA, et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation. 2014;129(1):57–65. doi: 10.1161/CIRCULATIONAHA.113.004526</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425–1436. doi: 10.1056/NEJMra040291</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Herrero T, Martin E, Poch DS, Roeder HA. Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension. J Matern Fetal Neonatal Med. 2018;31(9):1209–1213. doi: 10.1080/14767058.2017.1312329</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bentley JP, Roberts CL, Bowen JR, et al. Planned birth before 39 weeks and child development: a population-based study. Pediatrics. 2016;138(6): e20162002. doi: 10.1542/peds.2016–2002</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104(5 Pt 1):1005–1010. doi: 10.1097/01.AOG.0000142709.04450.bd</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Forrest P. Anaesthesia and right ventricular failure. Anaesth Intensive Care. 2009;37(3):370–385. doi: 10.1177/0310057X0903700314</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Hamlyn EL, Douglass CA, Plaat F, et al. Low-dose sequential combined spinalepidural: an anaesthetic technique for caesarean section in patients with significant cardiac disease. Int J Obstet Anesth. 2005;14(4):355–361. doi: 10.1016/j.ijoa.2005.01.001</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30(3):256–265. doi: 10.1093/eurheartj/ehn597</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases Anesthesiology. 2005;102(6): 1133–1137. doi: 10.1097/00000542-200506000-00012</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Meng ML, Landau R, Viktorsdottir O, et al. Pulmonary Hypertension in Pregnancy: A Report of 49 Cases at Four Tertiary North American Sites. Obstet Gynecol. 2017;129(3):511–520. doi: 10.1097/AOG.0000000000001896</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Curry RA, Fletcher C, Gelson E, et al. Pulmonary hypertension and pregnancy — a review of 12 pregnancies in nine women. BJOG. 2012;119(6):752–761. doi: 10.1111/j.1471-0528.2012.03295.x</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Price LC, Forrest P, Sodhi V, et al. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth. 2007;99(4):552–555. doi: 10.1093/bja/aem18</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Naoum EE, Chalupka A, Haft J, et al. Extracorporeal Life Support in Pregnancy: A Systematic Review. J Am Heart Assoc. 2020;9(13): e016072. doi: 10.1161/JAHA.119.016072</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart. 2014;100(3):231–238. doi: 10.1136/heartjnl-2013-304888</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Maxwell BG, El-Sayed YY, Riley ET, Carvalho B. Peripartum outcomes and anaesthetic management of parturients with moderate to complex congenital heart disease or pulmonary hypertension. Anaesthesia. 2013;68(1):52–59. doi: 10.1111/anae.12058.</mixed-citation></ref></ref-list></back></article>
